ATG5 and gastric cancer: Our present research found that inhibition of TRF2 in gastric cancer cells could significantly increase the expression of autophagy markers (ATG5 and LC3-II) and decrease the expression of the autophagic flux marker p62, indicating that TRF2 deficiency facilitated the process of autophagy in gastric cancer cells.